{
    "nctId": "NCT00109993",
    "briefTitle": "Campath-1H + FK506 and Methylprednisolone for GVHD",
    "officialTitle": "Phase II Clinical Trial Incorporating Alemtuzumab (Campath-1H) in Combination With FK506 and Methylprednisolone for Treatment of Severe Acute Graft vs Host Disease",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Chronic Myeloproliferative Disorders, Gestational Trophoblastic Tumor, Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases, Neuroblastoma, Ovarian Cancer, Testicular Germ Cell Tumor",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NA",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 34,
    "primaryOutcomeMeasure": "Graft-vs-host disease response",
    "eligibilityCriteria": "DISEASE CHARACTERISTICS:\n\n* Diagnosis of acute graft-vs-host disease (GVHD)\n\n  * Clinical grade C or D disease\n\n    * No grade C disease with single organ skin involvement\n* Has undergone allogeneic stem cell transplantation within the past 100 days\n\n  * Absolute neutrophil count \\> 500/mm\\^3 (donor-derived \\[\\> 60% by peripheral blood lymphocyte chimerism analyses\\])\n* No development of GVHD after prior donor lymphocyte infusion\n* Must have received prior prophylactic cyclosporine or tacrolimus at the onset of acute GVHD\n\nPATIENT CHARACTERISTICS:\n\nAge\n\n* Over 18\n\nPerformance status\n\n* Not specified\n\nLife expectancy\n\n* Not specified\n\nHematopoietic\n\n* See Disease Characteristics\n\nHepatic\n\n* No serologic evidence of active hepatitis B or C infection\n\nRenal\n\n* Creatinine \u2264 3.5 mg/dL\n* No requirement for dialysis\n\nCardiovascular\n\n* No requirement for vasopressors\n\nPulmonary\n\n* No requirement for a ventilator\n\nOther\n\n* Not pregnant\n* Negative pregnancy test\n* Fertile patients must use effective contraception during and for 6 months after completion of study treatment\n* No known HIV positivity\n* No active uncontrolled infection\n* No other organ dysfunction\n\nPRIOR CONCURRENT THERAPY:\n\nBiologic therapy\n\n* See Disease Characteristics\n\nChemotherapy\n\n* Not specified\n\nEndocrine therapy\n\n* Not specified\n\nRadiotherapy\n\n* Not specified\n\nSurgery\n\n* Not specified",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}